Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

575
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

506
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
506
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

566
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
566
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

460
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
460
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

613
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
613
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

358
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
358

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation discontinuation after atrial fibrillation ablation: A systematic review and meta-analysis of randomized and observational evidence.

Indian pacing and electrophysiology journal·2026
Same author

Rethinking thrombus risk in atrial flutter: Context matters.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology·2026
Same author

Cardiac Screening for Conditions Associated With Sudden Cardiac Death: Yield, Interventions, and SCA/SCD Incidence in 104,369 Young Individuals.

Journal of the American College of Cardiology·2026
Same author

Economic evaluation of a novel dual-energy, large focal lattice-tip catheter versus conventional contact-force sensing radiofrequency catheter, for persistent atrial fibrillation ablation, from the English National Health Service perspective.

Open heart·2026
Same author

Continuous smartwatch monitoring after atrial fibrillation ablation: feasibility of burden estimation and association with quality of life.

Frontiers in cardiovascular medicine·2026
Same author

Therapeutic Effects on Ectopic Burden and LV Ejection Fraction in a Patient With Aortic Stenosis Undergoing TAVR.

JACC. Case reports·2025

Related Experiment Video

Updated: Feb 8, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Premature Ventricular Complex-induced Cardiomyopathy.

Jorge G Panizo1, Sergio Barra1, Greg Mellor1

  • 1Royal Papworth Hospital NHS Foundation Trust, Cambridge University Health Partners Cambridge, UK.

Arrhythmia & Electrophysiology Review
|July 4, 2018
PubMed
Summary
This summary is machine-generated.

Frequent premature ventricular complexes (PVCs) can cause reversible left ventricular dysfunction. Catheter ablation is increasingly the first-line treatment for PVC-induced cardiomyopathy, offering an effective alternative to antiarrhythmic drugs.

Keywords:
Premature ventricular complex,antiarrhythmic drug;arrhythmia;cardiomyopathy,heart failure;non-sustained ventricular tachycardiaoutflow tract;palpitations;radiofrequency catheter ablation;ventricular dysfunction,

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

Related Experiment Videos

Last Updated: Feb 8, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure

Background:

  • Premature ventricular complexes (PVCs) can lead to left ventricular dysfunction, a condition known as PVC-induced cardiomyopathy.
  • The precise pathophysiological mechanisms underlying this condition are not fully understood.
  • Identifying risk factors and understanding cellular/extracellular mechanisms are ongoing research areas.

Purpose of the Study:

  • To review the current understanding of PVC-induced cardiomyopathy.
  • To discuss treatment strategies, including antiarrhythmic drugs and catheter ablation.
  • To highlight the evolving role of catheter ablation as a primary therapy.

Main Methods:

  • Literature review of studies on PVC-induced cardiomyopathy.
  • Analysis of treatment outcomes for antiarrhythmic drugs versus catheter ablation.
  • Evaluation of clinical scenarios favoring specific interventions.

Main Results:

  • PVC-induced cardiomyopathy is potentially reversible with PVC suppression.
  • Antiarrhythmic drugs have limitations including side effects and suboptimal efficacy.
  • Catheter ablation is effective but carries its own risks, yet is becoming a first-line therapy.

Conclusions:

  • Catheter ablation is increasingly considered the first-line treatment for PVC-induced cardiomyopathy.
  • Treatment decisions should weigh the risks and benefits of both antiarrhythmic drugs and ablation.
  • Specific patient scenarios may warrant early consideration of catheter ablation.